☆
Watchlist
Log in
Sign-up
Dominion Minerals Ltd (dlm) Logo

Dominion Minerals Ltd (DLM)

___:___ · Basic Materials
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials (10-yr)

DLM Chart

Snapshot

DLM's Principal Activity is the identification and diligence of potential new business opportunities for the Company.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +1498.21%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,830 of 2,413
Sector Rank 596 of 887

Key Fundamentals

Shares Issued
Sector Basic Materials
Similar Companies MM1 / QML / AQD
EPS -$0.008
DPS $0.00
Book Value Per Share $0.03

Broker Consensus

DLM is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Date Heading Pages File Size Time

Corporate Overview

Dominion Minerals Limited (DLM, formerly Factor Therapeutics Limited) is a mineral exploration company.

Incorporation Details

Incorporated Tissue Therapies Limited was incorporated on 6 September 2002 in Queensland

Corporate Details

Head Office Brisbane QLD 4000
Website www.dominion-minerals.com
Registry Link Market Services
Auditor PKF BRISBANE AUDIT
Date Listed 19 Mar 2004

Upcoming Calendar (Forecasted)

Date Event
27/07/2022 Report (Interim)
27/01/2023 Report (Quarterly)
29/03/2023 Report (Annual)
26/04/2023 Report (Quarterly)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.
Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Anastasios (Taso) Arima Non-Executive Director Nov 2021

Mr Anastasios (Taso) Arima

Non-Executive Director

Mr Arima has experience in the formation and development of energy and resource projects in North America and Europe.
Dominic Allen Non-Executive Director Nov 2021

Dominic Allen

Non-Executive Director

Mr Allen has more than 15 years' experience in the management and operations of natural resources organisations. Mr Allen is currently head of corporate development for Hyperion Metals (ASX:HYM), focused on the development of the titan heavy mineral sand project and associated titanium metal technologies in Tennessee, USA, having previously held senior roles with major resource organisations Rio Tinto Limited and Oyu Tolgoi LLC.
Mr Stephen Kelly Chief Financial Officer,Joint Company Secretary Oct 2021
Dr David Lionel Brookes Non-Executive Director,Non-Executive Chairman Apr 2019

Dr David Lionel Brookes

Non-Executive Director,Non-Executive Chairman

Dr Brookes has experience in the health and biotechnology industries and is currently a Non-Executive director of Anatara Ltd (ASX:ANR) and TALi Digital Limited (ASX:TD1). He has previously been a director of several other ASX listed biotechnology companies, most recently as the Chairman of genomics solutions company, RHS Ltd, which was acquired by PerkinElmer Inc in June 2018. Until its acquisition in January 2021, Dr Brookes was Non-Executive Chairman of the Better Medical Group, and maintains roles as a clinician and a biotechnology industry consultant. He is Member of Risk Management Committee.
Ms Melanie Farris Joint Company Secretary Sep 2016

Ms Melanie Farris

Joint Company Secretary

Ms Farris is an experienced governance and corporate operations professional and non-executive director with over 13 years' experience in listed life sciences companies, as well as experience in the planning, management and delivery of strategic corporate activities including IPO and M&A due diligence and integration. Ms Farris previously served as Non-Executive Director and Company Secretary for Invion Limited (ASX: IVX); and Chairperson of Synapse Australia Limited. She is currently Chief Governance and Risk Officer and Group Company Secretary for Telix Pharmaceuticals Limited (ASX:TLX).
Show All

Director Transactions

DLM directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
08/11/21 David Brookes Buy +2,500,000 $0.04 $100,000 As advised by the company
27/09/21 David Brookes Issued 500,000 $0.005 $2,500 Issue of options
27/09/21 David Brookes Issued 1,121,250 $0.04 $44,850 Director remuneration
27/09/21 David Brookes Transfer 250,000 $0.005 $1,250 As advised by the company
27/09/21 David Brookes Transfer 250,000 $0.005 $1,250 Off-market transfer
27/09/21 John Michailidis Issued 809,399 $0.04 $32,375 Director remuneration
Show All

Director Interests

The current holdings of DLM directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Dominic Allen 30/12/2021 910,624 1,500,000 1,303,541 N/A
Anastasios (Taso) Arima 30/12/2021 910,624 N/A 1,303,541 N/A
David Brookes 30/12/2021 N/A 4,901,250 500,000 N/A
Melanie Farris 01/11/2021 204,525 N/A 25,000 N/A
Show All

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Feb 28, 2022.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Calama Holdings Pty Ltd 9,156,250 4.42%
Ditm Holdings Pty Ltd 6,250,000 3.02%
Peter Croke Holdings Pty Ltd 4,600,000 2.22%
Citicorp Nominees Pty Limited 4,277,386 2.07%
Gp Securities Pty Ltd 4,235,799 2.05%
Arredo Pty Ltd 3,750,000 1.81%
Yelwac Pty Ltd 2,891,495 1.40%
Symington Pty Ltd 2,888,750 1.39%
Mrs Janice Annette Cawley 2,881,250 1.39%
Hsbc Custody Nominees (Australia) Limited 2,679,464 1.29%
Dr Alok Jhamb 2,600,000 1.26%
Fremont Sage Llc 2,500,000 1.21%
Mr Francis Xavier Parnis & Mrs Sally Jane Parnis 2,061,710 1.00%
Mrs Rachael Ann Crossley 1,970,000 0.95%
Mr Michael Andrew Whiting & Mrs Tracey Anne Whiting 1,818,859 0.88%
Nurragi Investments Pty Ltd 1,816,250 0.88%
Dr David Lionel Brookes & Mrs Elisabeth Brookes 1,780,000 0.86%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd 1,775,520 0.86%
Mrs Elisabeth Mary Brookes 1,750,000 0.84%
Cool Enterprises Pty Ltd 1,500,000 0.72%
Shadow Mountain Holdings Pty Ltd 1,500,000 0.72%
Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 452 669 264 635 304 2,324

Substantial Shareholders

No Substantial Shareholders for DLM in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
DLM Historical Price Data (CSV)
Up to 20 years of EOD share price history
Sign up to Download
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.